These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8408644

  • 21. Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice.
    Morikawa K, Fan D, Denkins YM, Levin B, Gutterman JU, Walker SM, Fidler IJ.
    Cancer Res; 1989 Feb 15; 49(4):799-805. PubMed ID: 2492206
    [Abstract] [Full Text] [Related]

  • 22. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 23. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M, Goedegebuure PS, Burger UL, Sadanaga N, Chang MP, Eberlein TJ.
    J Immunol; 1998 Jan 01; 160(1):334-44. PubMed ID: 9551989
    [Abstract] [Full Text] [Related]

  • 24. Towards endothelial-cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells.
    Ojeifo JO, Su N, Ryan US, Verma UN, Mazumder A, Zwiebel JA.
    Cytokines Mol Ther; 1996 Jun 01; 2(2):89-101. PubMed ID: 9384693
    [Abstract] [Full Text] [Related]

  • 25. Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.
    Cameron RB, McIntosh JK, Rosenberg SA.
    Cancer Res; 1988 Oct 15; 48(20):5810-7. PubMed ID: 3262413
    [Abstract] [Full Text] [Related]

  • 26. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L, Moschella F, Sestili P, La Sorsa V, Valentini M, Canini I, Baccarini S, Maccari S, Ramoni C, Belardelli F, Proietti E.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [Abstract] [Full Text] [Related]

  • 27. Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases.
    Komschlies KL, Gregorio TA, Gruys ME, Back TC, Faltynek CR, Wiltrout RH.
    J Immunol; 1994 Jun 15; 152(12):5776-84. PubMed ID: 8207207
    [Abstract] [Full Text] [Related]

  • 28. Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells.
    Ohno K, Yoshizawa H, Tsukada H, Takeda T, Yamaguchi Y, Ichikawa K, Maruyama Y, Suzuki Y, Suzuki E, Arakawa M.
    J Immunol; 1996 May 15; 156(10):3875-81. PubMed ID: 8621926
    [Abstract] [Full Text] [Related]

  • 29. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 30. Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells.
    Saitoh M, Taguchi K, Momose K, Suga K, Yamazaki N, Ono C, Suzuki T, Takeuchi O, Yasuda S, Miyata K.
    Cancer Chemother Pharmacol; 2002 Feb 15; 49(2):161-6. PubMed ID: 11862431
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K, Enomoto T, Fornasier V, Resetkova E, Volpé R.
    Proc Assoc Am Physicians; 1997 Mar 15; 109(2):126-35. PubMed ID: 9069581
    [Abstract] [Full Text] [Related]

  • 32. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB, Cestari S.
    Cell Immunol; 1997 May 25; 178(1):79-90. PubMed ID: 9184701
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Specific antitumor effect of lymphokine-activated lymphocytes obtained from tumor-bearing mice after intratumoral injection of interleukin-2 (IL-2)].
    Takahashi M.
    Nihon Geka Gakkai Zasshi; 1991 Mar 25; 92(3):247-56. PubMed ID: 2051976
    [Abstract] [Full Text] [Related]

  • 37. Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice.
    Iwanuma Y, Chen FA, Egilmez NK, Takita H, Bankert RB.
    Cancer Res; 1997 Jul 15; 57(14):2937-42. PubMed ID: 9230205
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.